Sign In
Buy LXRX
$1.85
-0.0400 (-2.12%)
At Close: Jun 03, 2026
Lexicon Pharmaceuticals to Host Third Quarter 2021 Financial Results Conference Call and Webcast on November 3, 2021
07:28pm, Thursday, 28'th Oct 2021
THE WOODLANDS, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its third quarter 2021 financial results on Wednesday, November 3, 2021 after the mar
6 Penny Stocks To Buy According To Analysts, Targets Up To 322%
12:20pm, Tuesday, 31'st Aug 2021
Analysts are bullish on these penny stocks, are you? The post 6 Penny Stocks To Buy According To Analysts, Targets Up To 322% appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
Lexicon Welcomes New ESC Heart Failure Treatment Guidelines Establishing SGLT Inhibitors as Standard of Care
07:00am, Monday, 30'th Aug 2021
New guidelines from the European Society of Cardiology recommend addition of SGLT inhibitors to standard of care for patients with acute and chronic heart failure.
Rapid benefit of sotagliflozin supported by data from the SOLOIST and SCORED trials presented at ESC Congress 2021 - The Digital Experience, including:
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Tops Revenue Estimates
09:54am, Friday, 30'th Jul 2021
Lexicon (LXRX) delivered earnings and revenue surprises of 18.75% and 680.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Lexicon Pharmaceuticals: Q2 Earnings Insights
07:21am, Friday, 30'th Jul 2021
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 80.00% over the past year to ($0.13), which beat the
Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
07:01am, Friday, 30'th Jul 2021
THE WOODLANDS, Texas, July 30, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that Craig Granowitz, M.D., Ph.D. will join the company as senior vice president a
Lexicon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical Update
07:00am, Friday, 30'th Jul 2021
Conference Call and Webcast at 8:00 am Eastern Time Conference Call and Webcast at 8:00 am Eastern Time
Lexicon Pharmaceuticals to Host Second Quarter 2021 Financial Results Conference Call and Webcast on July 30, 2021
05:40pm, Wednesday, 28'th Jul 2021
THE WOODLANDS, Texas, July 28, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2021 financial results on Friday, July 30, 2021 before the markets
LXRX Stock Price Increased 18.67%: Why It Happened
09:52am, Saturday, 26'th Jun 2021
The stock price of Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) increased 18.67% yesterday. This is why it happened.
Lexicon Pharmaceuticals Announces Symposium at the American Diabetes Association 81st Scientific Sessions
08:00am, Friday, 25'th Jun 2021
THE WOODLANDS, Texas, June 25, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be a symposium highlighting sotagliflozin followed by a live video ques
Lexicon Pharmaceuticals Still A Very High-Risk/High-Reward Biopharma Name
03:30pm, Thursday, 27'th May 2021
"Steady as she goes" isn't enough for Lexicon; Zynquista really needs a partner to effectively compete in the market, particularly if upcoming trial data from AstraZeneca and Lilly/Boehringer are posi
Lexicon Pharmaceuticals Announces Two Presentations at the American College of Cardiology's 70th Annual Scientific Session
04:15pm, Thursday, 13'th May 2021
THE WOODLANDS, Texas, May 13, 2021 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be two virtual presentations highlighting sotagliflozin during the Ameri
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript
12:50am, Friday, 07'th May 2021
Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates
09:47pm, Thursday, 06'th May 2021
Lexicon (LXRX) delivered earnings and revenue surprises of 11.76% and -99.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
